Products
2660 products
Code | Description | Unit |
---|---|---|
EPY0000382 | Famotidine for system suitability | EP unit |
EPY0000383 | All-rac-alpha-tocopherol for peak identification | EP unit |
EPY0000384 | All-rac-alpha-tocopheryl acetate for peak identification | EP unit |
EPY0000385 | 1,4-Sorbitan | EP unit |
EPY0000386 | Foeniculin for peak identification Anise oil | EP unit |
EPY0000387 | Pseudoisoeugenyl 2-methylbutyrate for peak identification | EP unit |
EPY0000388 | Newcastle Disease Vaccine (inacativated) BRP | EP unit |
EPY0000389 | Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) | EP unit |
EPY0000390 | Oxeladin impurity D - 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate | EP unit |
EPY0000391 | Betahistine dihydrochloride | EP unit |
EPY0000392 | Closantel sodium dihydrate | EP unit |
EPY0000393 | Closantel for system suitability (Closantel sodium dihydrate) | EP unit |
EPY0000394 | Dipivefrine for system suitability | EP unit |
EPY0000395 | Granisetron impurity E - (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine | EP unit |
EPY0000396 | Granisetron hydrochloride | EP unit |
EPY0000397 | Lysine acetate | EP unit |
EPY0000398 | Methyl nicotinate | EP unit |
EPY0000399 | Naproxen (racemic) | EP unit |
EPY0000400 | Naltrexone hydrochloride | EP unit |
EPY0000401 | Pimobendan for system suitability | EP unit |
EPY0000402 | Pyrantel embonate | EP unit |
EPY0000403 | Pyrantel impurity A - 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine | EP unit |
EPY0000404 | Oxeladin impurity C - 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate | EP unit |
EPY0000405 | Salicylic acid impurity B - 4-hydroxyisophthalic acid | EP unit |
EPY0000406 | Iopamidol impurity H - 4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5- (2-hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide | EP unit |
EPY0000407 | Methylrosanilinium chloride for system suitability | EP unit |
EPY0000408 | Stavudine | EP unit |
EPY0000409 | Famotidine impurity D -: 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide | EP unit |
EPY0000410 | Naltrexone impurity C - N-(3-butenyl)-noroxymorphone | EP unit |
EPY0000411 | Ranitidine for system suitability | EP unit |
EPY0000412 | Sulfamethoxazole impurity A - N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide | EP unit |
EPY0000413 | Sulfamethoxazole impurity F - 4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide | EP unit |
EPY0000414 | Tiamulin for peak identification | EP unit |
EPY0000415 | Felypressin | EP unit |
EPY0000416 | Ranitidine impurity J - 1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1-diamine) | EP unit |
EPY0000417 | Pentazocine lactate - Reference Spectrum | EP unit |
EPY0000418 | Methylrosanilinium chloride | EP unit |
EPY0000419 | Fludarabine phosphate | EP unit |
EPY0000420 | Cefotaxime acid | EP unit |
EPY0000421 | Stavudine for system suitability | EP unit |
EPY0000422 | Salmeterol xinafoate | EP unit |
EPY0000423 | Salmeterol xinafoate for system suitability | EP unit |
EPY0000424 | Atracurium besilate | EP unit |
EPY0000425 | Lamivudine | EP unit |
EPY0000426 | Lamivudine for system suitability 2 | EP unit |
EPY0000427 | Acarbose for peak identification | EP unit |
EPY0000428 | Methanol - Reference Spectrum | EP unit |
EPY0000429 | Trospium chloride | EP unit |
EPY0000430 | Trospium impurity C - (1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] | EP unit |
EPY0000431 | Trospium impurity B - (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate | EP unit |
EPY0000432 | Trospium impurity A - Hydroxydiphenylacetic acid (benzilic acid) | EP unit |
EPY0000433 | Ammonium glycyrrhizate | EP unit |
EPY0000434 | Boldine | EP unit |
EPY0000435 | Captopril impurity E - (2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid | EP unit |
EPY0000436 | Chlorphenamine impurity A - 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile | EP unit |
EPY0000437 | Chlorphenamine impurity C - (3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine | EP unit |
EPY0000438 | Coumarin | EP unit |
EPY0000439 | Didanosine | EP unit |
EPY0000440 | Didanosine for system suitability | EP unit |
EPY0000441 | Didanosine impurity A - 1,7-dihydro-6H-purin-6-one (hypoxanthine) | EP unit |
EPY0000442 | Didanosine impurity G - 9-(2,3-dideoxy-beta-D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-dideoxyadenosine) | EP unit |
EPY0000443 | Flunixin meglumine | EP unit |
EPY0000444 | Flunixin impurity B - 2-methyl-3-(trifluoromethyl)aniline | EP unit |
EPY0000445 | Flunixin impurity C - ethyl 2-chloropyridine-3-carboxylate | EP unit |
EPY0000447 | Hyoscine butylbromide impurity E - (1R,2R,4S,5S,7S)-9-butyl-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-3-oxa-9-azoni atricyclo[3.3.1.02,4]nonane | EP unit |
EPY0000448 | Hyoscine hydrobromide impurity B - (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl(2S)- 3-hydroxy-2-phenylpropanoate | EP unit |
EPY0000449 | Hyoscyamine impurity E - (1R,3s,5S)-8-azabicyclo[3.2.1] oct-3-yl(2S)-3-hydroxy-2-phenylpropanoate | EP unit |
EPY0000453 | Oxycodone impurity D - 7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy-17- methylmorphinan-6-one (14-hydroxycodeinone) | EP unit |
EPY0000454 | Diacetylfluorescein | EP unit |
EPY0000455 | Propafenone hydrochloride | EP unit |
EPY0000456 | Propafenone impurity B - (2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy] phenyl]-3-phenylprop-2-en-1-one | EP unit |
EPY0000457 | Repaglinide | EP unit |
EPY0000458 | Repaglinide for system suitability | EP unit |
EPY0000459 | Repaglinide impurity E - 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid | EP unit |
EPY0000460 | Tetryzoline hydrochloride | EP unit |
EPY0000461 | Torasemide anhydrous | EP unit |
EPY0000462 | Torasemide for system suitability | EP unit |
EPY0000463 | Vinorelbine tartrate | EP unit |
EPY0000464 | Vinorelbine impurity B - 4-O-deacetylvinorelbine | EP unit |
EPY0000465 | Ticarcillin monosodium | EP unit |
EPY0000466 | Povidone (iodinated) | EP unit |
EPY0000467 | Thiamine hydrochloride | EP unit |
EPY0000469 | Beclometasone dipropionate for peak identification | EP unit |
EPY0000470 | Brotizolam impurity B - 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine (demethylbrotizolam) | EP unit |
EPY0000471 | Buspirone for system suitability | EP unit |
EPY0000472 | Cabergoline | EP unit |
EPY0000473 | Calcipotriol monohydrate | EP unit |
EPY0000474 | Calcipotriol monohydrate - Reference Spectrum | EP unit |
EPY0000475 | Carboprost trometamol | EP unit |
EPY0000476 | Chlordiazepoxide impurity A - 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide | EP unit |
EPY0000477 | Granisetron impurity A - 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1] non-3-yl]-2H-indazole-3-carboxamide | EP unit |
EPY0000478 | Granisetron impurity B - N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide | EP unit |
EPY0000479 | Chlorpromazine impurity D - 3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (demethylchlorpromazine) | EP unit |
EPY0000480 | Dibrompropamidine diisetionate | EP unit |
EPY0000481 | Dibrompropamidine for system suitability (Dibrompropamidine diisetionate) | EP unit |
EPY0000482 | Dihydrotachysterol for system suitability | EP unit |
EPY0000483 | Hyoscine | EP unit |
EPY0000484 | Hyoscine impurity A - (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscine) | EP unit |
EPY0000485 | Myo-inositol | EP unit |
EPY0000486 | Ketorolac trometamol | EP unit |